The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Gene Review

DIANPH  -  diabetic nephropathy

Homo sapiens

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of DIANPH


Psychiatry related information on DIANPH


High impact information on DIANPH


Chemical compound and disease context of DIANPH


Biological context of DIANPH


Anatomical context of DIANPH


Associations of DIANPH with chemical compounds


Physical interactions of DIANPH


Regulatory relationships of DIANPH


Other interactions of DIANPH


Analytical, diagnostic and therapeutic context of DIANPH


  1. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. Brenner, B.M., Cooper, M.E., de Zeeuw, D., Keane, W.F., Mitch, W.E., Parving, H.H., Remuzzi, G., Snapinn, S.M., Zhang, Z., Shahinfar, S. N. Engl. J. Med. (2001) [Pubmed]
  2. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. Mangili, R., Bending, J.J., Scott, G., Li, L.K., Gupta, A., Viberti, G. N. Engl. J. Med. (1988) [Pubmed]
  3. Effect of captopril on heavy proteinuria in azotemic diabetics. Taguma, Y., Kitamoto, Y., Futaki, G., Ueda, H., Monma, H., Ishizaki, M., Takahashi, H., Sekino, H., Sasaki, Y. N. Engl. J. Med. (1985) [Pubmed]
  4. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. Parving, H.H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., Arner, P. N. Engl. J. Med. (2001) [Pubmed]
  5. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. Zeller, K., Whittaker, E., Sullivan, L., Raskin, P., Jacobson, H.R. N. Engl. J. Med. (1991) [Pubmed]
  6. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Caramori, M.L., Fioretto, P., Mauer, M. Diabetes (2000) [Pubmed]
  7. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Ng, D.P., Tai, B.C., Koh, D., Tan, K.W., Chia, K.S. Diabetologia (2005) [Pubmed]
  8. Antihypertensive treatment and multifactorial approach for renal protection in diabetes. Fioretto, P., Solini, A. J. Am. Soc. Nephrol. (2005) [Pubmed]
  9. Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Kimmerle, R., Zass, R.P., Cupisti, S., Somville, T., Bender, R., Pawlowski, B., Berger, M. Diabetologia (1995) [Pubmed]
  10. Diabetic nephropathy: a frontier for personalized medicine. Susztak, K., Böttinger, E.P. J. Am. Soc. Nephrol. (2006) [Pubmed]
  11. Reversal of lesions of diabetic nephropathy after pancreas transplantation. Fioretto, P., Steffes, M.W., Sutherland, D.E., Goetz, F.C., Mauer, M. N. Engl. J. Med. (1998) [Pubmed]
  12. Studies of kidney and muscle biopsy specimens from identical twins discordant for type I diabetes mellitus. Steffes, M.W., Sutherland, D.E., Goetz, F.C., Rich, S.S., Mauer, S.M. N. Engl. J. Med. (1985) [Pubmed]
  13. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. Beisswenger, P.J., Moore, L.L., Brinck-Johnsen, T., Curphey, T.J. J. Clin. Invest. (1993) [Pubmed]
  14. 48 year old male with sudden onset of right sided weakness. Easton, A. Brain Pathol. (2006) [Pubmed]
  15. Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1. Poczatek, M.H., Hugo, C., Darley-Usmar, V., Murphy-Ullrich, J.E. Am. J. Pathol. (2000) [Pubmed]
  16. The immunohistopathology of glomerular antigens. III. Increased mesangial actomyosin in experimental diabetes in the rat. Scheinman, J.I., Steffes, M.W., Brown, D.M., Mauer, S.M. Diabetes (1978) [Pubmed]
  17. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. Lewis, E.J., Hunsicker, L.G., Bain, R.P., Rohde, R.D. N. Engl. J. Med. (1993) [Pubmed]
  18. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. Seaquist, E.R., Goetz, F.C., Rich, S., Barbosa, J. N. Engl. J. Med. (1989) [Pubmed]
  19. Advanced glycosylation end products in patients with diabetic nephropathy. Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E.A., Cerami, A., Vlassara, H. N. Engl. J. Med. (1991) [Pubmed]
  20. Apoptosis and loss of renal tissue in polycystic kidney diseases. Woo, D. N. Engl. J. Med. (1995) [Pubmed]
  21. The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control. Selby, J.V., FitzSimmons, S.C., Newman, J.M., Katz, P.P., Sepe, S., Showstack, J. JAMA (1990) [Pubmed]
  22. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. Skolnik, E.Y., Yang, Z., Makita, Z., Radoff, S., Kirstein, M., Vlassara, H. J. Exp. Med. (1991) [Pubmed]
  23. Glomerulopathy in rats with streptozotocin diabetes. Accumulation of glomerular basement membrane analogous to human diabetic nephropathy. Cohen, M.P., Klein, C.V. J. Exp. Med. (1979) [Pubmed]
  24. Podocyte loss and progressive glomerular injury in type II diabetes. Pagtalunan, M.E., Miller, P.L., Jumping-Eagle, S., Nelson, R.G., Myers, B.D., Rennke, H.G., Coplon, N.S., Sun, L., Meyer, T.W. J. Clin. Invest. (1997) [Pubmed]
  25. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. Niwa, T., Katsuzaki, T., Miyazaki, S., Miyazaki, T., Ishizaki, Y., Hayase, F., Tatemichi, N., Takei, Y. J. Clin. Invest. (1997) [Pubmed]
  26. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. Parving, H.H. N. Engl. J. Med. (1994) [Pubmed]
  27. Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. Myers, B.D., Nelson, R.G., Williams, G.W., Bennett, P.H., Hardy, S.A., Berg, R.L., Loon, N., Knowler, W.C., Mitch, W.E. J. Clin. Invest. (1991) [Pubmed]
  28. Role of TGF-beta/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model. Ricci, C., Iacobini, C., Oddi, G., Amadio, L., Menini, S., Rastaldi, M.P., Frasheri, A., Pricci, F., Pugliese, F., Pugliese, G. Nephrol. Dial. Transplant. (2006) [Pubmed]
  29. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. Hadjadj, S., Belloum, R., Bouhanick, B., Gallois, Y., Guilloteau, G., Chatellier, G., Alhenc-Gelas, F., Marre, M. J. Am. Soc. Nephrol. (2001) [Pubmed]
  30. Connective tissue growth factor and igf-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Lam, S., van der Geest, R.N., Verhagen, N.A., van Nieuwenhoven, F.A., Blom, I.E., Aten, J., Goldschmeding, R., Daha, M.R., van Kooten, C. Diabetes (2003) [Pubmed]
  31. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Hohenstein, B., Hausknecht, B., Boehmer, K., Riess, R., Brekken, R.A., Hugo, C.P. Kidney Int. (2006) [Pubmed]
  32. Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells. Lee, H.S., Moon, K.C., Song, C.Y., Kim, B.C., Wang, S., Hong, H.K. Am. J. Physiol. Renal Physiol. (2004) [Pubmed]
  33. Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Lang, F., Klingel, K., Wagner, C.A., Stegen, C., Warntges, S., Friedrich, B., Lanzendorfer, M., Melzig, J., Moschen, I., Steuer, S., Waldegger, S., Sauter, M., Paulmichl, M., Gerke, V., Risler, T., Gamba, G., Capasso, G., Kandolf, R., Hebert, S.C., Massry, S.G., Broër, S. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  34. C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells. Al-Rasheed, N.M., Willars, G.B., Brunskill, N.J. J. Am. Soc. Nephrol. (2006) [Pubmed]
  35. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Ray, D., Mishra, M., Ralph, S., Read, I., Davies, R., Brenchley, P. Diabetes (2004) [Pubmed]
  36. SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy. Kim, J.H., Shin, H.D., Park, B.L., Moon, M.K., Cho, Y.M., Hwang, Y.H., Oh, K.W., Kim, S.Y., Lee, H.K., Ahn, C., Park, K.S. Diabetes (2006) [Pubmed]
  37. Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes. Nakajima, K., Tanaka, Y., Nomiyama, T., Ogihara, T., Piao, L., Sakai, K., Onuma, T., Kawamori, R. Diabetes (2002) [Pubmed]
  38. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy. McLennan, S.V., Martell, S.K., Yue, D.K. Diabetes (2002) [Pubmed]
  39. Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients. Barbosa, J., Steffes, M.W., Sutherland, D.E., Connett, J.E., Rao, K.V., Mauer, S.M. JAMA (1994) [Pubmed]
  40. Abnormal Na+/H+ antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. Ng, L.L., Davies, J.E., Siczkowski, M., Sweeney, F.P., Quinn, P.A., Krolewski, B., Krolewski, A.S. J. Clin. Invest. (1994) [Pubmed]
  41. Treatment of end-stage renal failure due to diabetes in the United Kingdom, 1975-84. Cameron, J.S., Challah, S. Lancet (1986) [Pubmed]
  42. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Pedrini, M.T., Levey, A.S., Lau, J., Chalmers, T.C., Wang, P.H. Ann. Intern. Med. (1996) [Pubmed]
WikiGenes - Universities